Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme

American Journal of Pathology

Volumn 162, Issue 1, 2003, Pages 11-17

  Bacher, Michael ^a,d   Schrader, Jörg ^a   Thompson, Nancy ^c   Kuschela, Karen ^a   Gemsa, Diethard ^a   Waeber, Gérard ^c   Schlegel, Jürgen ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d Institute of Immunology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MACROPHAGE MIGRATION INHIBITION FACTOR;

ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE RELEASE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HYPOGLYCEMIA; HYPOXIA; IMMUNE SYSTEM; IMMUNOHISTOLOGY; NECROSIS; NEOVASCULARIZATION (PATHOLOGY); NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STRESS; TRANSCRIPTION INITIATION; TUMOR CELL; TUMOR SUPPRESSOR GENE;

EID: 0037223573     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63793-5     Document Type: Article

References (26)

1. Holland EC: Glioblastoma multiforme: The terminator. Proc Natl Acad Sci USA 2000, 97:6242-6244
2. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848
3. David JR, Bozza M, Carini C: Macrophage migration inhibitory factor. Human Cytokines Handbook for Basic and Clinical Research, Vol 2. Edited by BB Aggraval, JU Gutterman. Cambridge, Blackwell Science, 1996, pp 222-256
4. Bucala R: MIF rediscovered: Cytokine, pituitary hormone, and glucocorticoid regulator of the immune response. EMBO J 1996, 10:1607-1613
5. Lan HY, Mu W, Yang N, Meinhardt A, Nikolic-Paterson DJ, Ng YY, Bacher M, Atkins RC, Bucala R: De novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol 1996, 149:1119-1127
6. Meinhardt A, Bacher M, McFarlane JR, Metz CN, Seitz J, Hedger MP, de Kretser DM, Bucala R: The macrophage migration inhibitory factor (MIF) production by Leydig cells: Evidence for a role in regulation of testicular function. Endocrinology 1996, 137:5090-5095
7. Bacher M, Meinhardt A, Lan HY, Mu W, Metz CN, Chesney JA, Calandra T, Gemsa D, Donnelly T, Atkins RC, Bucala R: MIF expression in experimentally-induced endotoxemia. Am J Pathol 1997, 150: 235-246
8. Waeber G, Calandra T, Roduit R, Haefliger JA, Thompson N, Thorens B, Temler E, Meinhardt A, Bacher M, Metz CN, Nicod P, Bucala R: Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Nall Acad Sci USA 1997, 94:4782-4787
9. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R: MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993, 365:756-759
10. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R: MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995, 377:68-71
11. Mikulowska A, Metz CN, Bucala R, Holmdahl R: Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 1997, 158:5514-5517
12. Lan HY, Bacher M, Yang N, Mu W, Nikolic-Paterson DJ, Metz C, Meinhardt A, Bucala R, Atkins RC: The pathogenic role of macrophage migration inhibitory factor in immunological induced kidney disease in the rat. J Exp Med 1997, 185:1455-1465
13. Shimizu T, Ohkawara A, Nishihira J, Sakamoto W: Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localization. FEBS Lett 1996, 381:199-202
14. Mitchell RA, Metz CN, Peng T, Bucala R: Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). J Biol Chem 1999, 274:18100-18106
15. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R: An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 1999, 5:181-191
16. Shimizu T, Abe R, Nakamura H, Ohkawara A, Suzuki M, Nishihira J: High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem Biophys Res Commun 1999, 264:751-758
17. Koon AC, Denko NC, Hudson KM, Schindler C, Swiersz L, Koch C, Evans S, Ibrahim H, Le QT, Terris DJ, Glaccia AJ: Candidate genes for the hypoxic phenotype. Cancer Res 2000, 60:883-887
18. Markert JM, Fuller CM, Gillespie GY, Bubien JK, McLean LA, Hong RL, Lee K, Gullans SR, Mapstone TB, Benos DJ: Differential gene expression profiling in human brain tumors. Physiol Genomics 2001, 5:21-33
19. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH: A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 1999, 190:375-382
20. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, Bucala R: Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response. Proc Natl Acad Sci USA 2002, 99:345-350
21. Sambrook J: Molecular Cloning: A Laboratory Manual. Edited by EF Fritsch, T Maniatis. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989, p 7.51
22. Waeber G, Thompson N, Chautard T, Steinmann M, Nicod P, Pralong FP, Calandra T, Gaillard RC: Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3′,5′-monophosphate responsive element-binding protein CREB in pituitary cells. Mol Endocrinol 1998, 12:698-705
23. Takahashi N, Nishihira J, Sato Y, Kondo M, Ogawa H, Ohshima T, Une Y, Todo S: Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor growth. Mol Med 1998, 4:707-714
24. Kleihues P, Ohgaki H: Primary and secondary glioblastoma: From concept to clinical diagnosis. Neuro-Oncology 1999, 1:44-51
25. Kraus A, Gross MW, Knuechel R, Munkel K, Neff F, Schlegel J: Aberrant p21 regulation in radioresistant primary glioblastoma multiforme cells bearing wild-type p53. J Neurosurg 2000, 93:863-872
26. Bogler O, Huang HJ, Kleihues P, Cavenee WK: The p53 gene and its role in human brain tumors. Glia 1995, 15:308-327